Jean Dinh

608 total citations
20 papers, 409 citations indexed

About

Jean Dinh is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Jean Dinh has authored 20 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Oncology. Recurrent topics in Jean Dinh's work include Pharmacogenetics and Drug Metabolism (12 papers), Pharmaceutical studies and practices (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Jean Dinh is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Pharmaceutical studies and practices (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Jean Dinh collaborates with scholars based in United States, United Kingdom and Canada. Jean Dinh's co-authors include Andrea Gaedigk, J. Steven Leeder, Bhagwat Prasad, Hyunyoung Jeong, José de León, Jacob T. Brown, Erika L. Nurmi, Kelly E. Caudle, Teri E. Klein and James T. McCracken and has published in prestigious journals such as International Journal of Molecular Sciences, Clinical Pharmacology & Therapeutics and Frontiers in Pharmacology.

In The Last Decade

Jean Dinh

19 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean Dinh United States 8 253 140 69 68 62 20 409
Anne‐Marie Buunk Netherlands 7 200 0.8× 100 0.7× 45 0.7× 47 0.7× 62 1.0× 7 303
M.E.G. Naranjo Spain 10 305 1.2× 76 0.5× 55 0.8× 114 1.7× 67 1.1× 12 425
Carmen Belmonte Spain 14 188 0.7× 111 0.8× 47 0.7× 84 1.2× 66 1.1× 21 455
Katarzyna Drozda United States 11 337 1.3× 110 0.8× 66 1.0× 52 0.8× 63 1.0× 16 440
Gina Mejía‐Abril Spain 15 259 1.0× 128 0.9× 123 1.8× 108 1.6× 69 1.1× 49 647
Wim J. Tamminga Netherlands 10 264 1.0× 85 0.6× 60 0.9× 105 1.5× 88 1.4× 13 492
Bianca Soree Netherlands 7 167 0.7× 85 0.6× 45 0.7× 38 0.6× 60 1.0× 11 272
M. Rebsamen Switzerland 11 305 1.2× 158 1.1× 191 2.8× 113 1.7× 88 1.4× 14 742
Humberto Fariñas Spain 10 217 0.9× 67 0.5× 44 0.6× 81 1.2× 42 0.7× 17 345
Marcos Navares‐Gómez Spain 12 171 0.7× 73 0.5× 60 0.9× 64 0.9× 49 0.8× 35 361

Countries citing papers authored by Jean Dinh

Since Specialization
Citations

This map shows the geographic impact of Jean Dinh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Dinh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Dinh more than expected).

Fields of papers citing papers by Jean Dinh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Dinh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Dinh. The network helps show where Jean Dinh may publish in the future.

Co-authorship network of co-authors of Jean Dinh

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Dinh. A scholar is included among the top collaborators of Jean Dinh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Dinh. Jean Dinh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Moore, Holly, Aki T. Heikkinen, Sibylle Neuhoff, et al.. (2025). Investigating Sulfotransferase Mediated Drug Interactions of Ethinylestradiol using a Physiologically Based Pharmacokinetic Model. The AAPS Journal. 28(1). 13–13.
4.
Johnson, Trevor N., et al.. (2024). Combining data on the bioavailability of midazolam and physiologically‐based pharmacokinetic modeling to investigate intestinal CYP3A4 ontogeny. CPT Pharmacometrics & Systems Pharmacology. 13(9). 1570–1581. 3 indexed citations
6.
Zubiaur, Pablo, Erin C. Boone, Jean Dinh, et al.. (2023). Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity. Clinical Pharmacology & Therapeutics. 114(5). 1033–1042. 9 indexed citations
7.
Dinh, Jean, Trevor N. Johnson, Manuela Grimstein, & Tamorah Lewis. (2023). Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities. Pharmaceutics. 15(11). 2579–2579. 7 indexed citations
8.
Shi, Yuanyuan, Jean Dinh, Brianne S. Raccor, et al.. (2022). Selective deuteration of bupropion slows epimerization and reduces metabolism. Bioorganic & Medicinal Chemistry Letters. 76. 129009–129009. 1 indexed citations
9.
Dinh, Jean, Scott Heyward, Bhagwat Prasad, et al.. (2022). Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation. International Journal of Molecular Sciences. 23(20). 12433–12433. 3 indexed citations
10.
Leeder, J. Steven, Jean Dinh, Andrea Gaedigk, et al.. (2021). Ontogeny of Scaling Factors for Pediatric Physiology-Based Pharmacokinetic Modeling and Simulation: Microsomal Protein Per Gram of Liver. Drug Metabolism and Disposition. 50(1). 24–32. 14 indexed citations
11.
Dinh, Jean, et al.. (2021). Is this the end for ranitidine? NDMA presence continues to confound. Clinical and Translational Science. 14(4). 1197–1200. 14 indexed citations
12.
Dinh, Jean, Erin C. Boone, Vincent S. Staggs, et al.. (2021). The Impact of the CYP2D6 “Enhancer” Single Nucleotide Polymorphism on CYP2D6 Activity. Clinical Pharmacology & Therapeutics. 111(3). 646–654. 6 indexed citations
13.
Chapron, Brian D., Jean Dinh, Paul Toren, Andrea Gaedigk, & J. Steven Leeder. (2020). The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites. Drug Metabolism and Disposition. 48(11). 1113–1120. 5 indexed citations
14.
Dinh, Jean, Chelsea M. Hosey, & Bridgette L. Jones. (2020). Pediatric Clinical Endpoint and Pharmacodynamic Biomarkers: Limitations and Opportunities. Pediatric Drugs. 22(1). 55–71. 3 indexed citations
15.
Sandritter, Tracy, et al.. (2019). Description of an Innovative Pediatric Individualized Therapeutics Clinic: Working toward Precision Drug Therapy. Children. 6(2). 35–35. 4 indexed citations
16.
Brown, Jacob T., Jeffrey R. Bishop, Katrin Sangkuhl, et al.. (2019). Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy. Clinical Pharmacology & Therapeutics. 106(1). 94–102. 136 indexed citations
17.
Gaedigk, Andrea, Jean Dinh, Hyunyoung Jeong, Bhagwat Prasad, & J. Steven Leeder. (2018). Ten Years’ Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics. Journal of Personalized Medicine. 8(2). 15–15. 106 indexed citations
18.
Dinh, Jean, Robin E. Pearce, Leon van Haandel, Andrea Gaedigk, & J. Steven Leeder. (2016). Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children. Drug Metabolism and Disposition. 44(7). 1070–1079. 22 indexed citations
19.
Lewis, Tamorah, Jean Dinh, & JS Leeder. (2015). Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research. Clinical Pharmacology & Therapeutics. 98(3). 309–320. 17 indexed citations
20.
Raccor, Brianne S., Jean Dinh, Julie R. Park, et al.. (2011). Potential Contribution of Cytochrome P450 2B6 to Hepatic 4-Hydroxycyclophosphamide Formation In Vitro and In Vivo. Drug Metabolism and Disposition. 40(1). 54–63. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026